2025 |
HDFC Bank Ltd.
|
Independent Director |
61.5 L |
12.4 % |
2025 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
24 L |
-2.0 % |
2024 |
HDFC Bank Ltd.
|
Independent Director |
54.7 L |
14.0 % |
2024 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
24.5 L |
2.1 % |
2023 |
HDFC Bank Ltd.
|
Independent Director |
48 L |
17.1 % |
2023 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
24 L |
23.1 % |
2022 |
HDFC Bank Ltd.
|
Independent Director |
41 L |
- |
2022 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
19.5 L |
11.0 % |
2021 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Independent Director |
17.6 L |
- |
2021 |
HDFC Bank Ltd.
|
Independent Director |
- |
- |
2020 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Additional Independent Director |
- |
- |
2020 |
HDFC Bank Ltd.
|
Additional Independent Director |
- |
- |
2019 |
GlaxoSmithKline Pharmaceuticals Ltd.
|
Additional Independent Director |
- |
- |